Monopar Therapeutics
MNPR· Nasdaq
MNPRMonopar Therapeutics
Filed Mar 27, 2020 · 10-K · 87 days after period end · 0001654954-20-003363
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018 | Q4 2017dderived from reported figures |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.21M | -$890.46K | -$713.59K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Monopar Therapeutics · CIK 1645469 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 27, 2020 · 87 d after period end
